Research Topics
| S H HohnloserSummaryAffiliation: Frankfurt am Main Country: Germany Publications
| Collaborators
|
Detail Information
Publications
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)Stefan H Hohnloser
Division of Electrophysiology, Department of Cardiology, J W Goethe University, Frankfurt, Germany
Am Heart J 152:442-7. 2006..This substudy will determine if atrial electrical remodeling is detectable in pacemaker patients and if it is associated with the development of AF...
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialStefan H Hohnloser
Division of Clinical Electrophysiology, Department of Cardiology, J W Goethe University, Theodor Stern Kai 7, Frankfurt D 60590, Germany
Eur Heart J 33:2821-30. 2012..Apixaban, a novel oral anticoagulant with partial renal excretion, was compared with warfarin and reduced the rate stroke, death and bleeding in the ARISTOTLE trial. We evaluated these outcomes in relation to renal function...
Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERTStefan H Hohnloser
J W Goethe University, Theodor Stern Kai 7, Frankfurt, Germany
Heart Rhythm 9:1667-73. 2012..Pacing algorithms to prevent atrial fibrillation (AF) have been tested in studies of modest size and duration with inconclusive results...
Dabigatran for stroke prevention in atrial fibrillationS H Hohnloser
J W Goethe University, Frankfurt am Main, Germany
Hamostaseologie 32:216-20. 2012..There were numerically more myocardial infarcts in dabigatran-treated patients than in warfarin patients; however, other myocardial ischaemic events were similar in the three treatment arms...
Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trialStefan H Hohnloser
Division of Clinical Electrophysiology, J W Goethe University Hospital, Theodor Stern Kai 7, Frankfurt, Germany
Circulation 125:669-76. 2012..There is a modest risk of myocardial infarction (MI) and myocardial ischemic events in patients with atrial fibrillation...
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atriaStefan H Hohnloser
J W Goethe University, Department of Cardiology, Frankfurt, Germany
J Cardiovasc Electrophysiol 19:69-73. 2008..There is a continued need for new antiarrhythmic drugs to treat the ever-increasing number of patients with this arrhythmia. Dronedarone is a new antiarrhythmic compound currently being developed for treatment of AF...
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trialStefan H Hohnloser
Division of Electrophysiology, Department of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
Eur Heart J 27:3027-32. 2006..The purpose of this study was to assess the incidence, features, and clinical sequelae of 'electrical storm' (ES)...
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trialStefan H Hohnloser
Department of Medicine, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
Circulation 114:104-9. 2006..The effects of these drugs on defibrillation energy requirements have not been previously assessed in a randomized controlled trial...
Ventricular arrhythmias: antiadrenergic therapy for the patient with coronary artery diseaseStefan H Hohnloser
J W Goethe University, Frankfurt, Germany
J Cardiovasc Pharmacol Ther 10:S23-31. 2005..In addition, several studies have shown that combination therapy with beta-blockers and implantable cardioverter defibrillators have synergistic effects that optimize the benefits of both therapies...
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarctionStefan H Hohnloser
Department of Medicine, Division of Cardiology, J W Goethe University, Frankfurt, Germany
N Engl J Med 351:2481-8. 2004..Whether benefit occurs in patients early after myocardial infarction is unknown...
[Drug therapy of ventricular arrhythmias - a contemporary perspective]G C Grönefeld
Johann Wolfgang Goethe Universitat, Medizinische Klinik IV, Frankfurt am Main, Germany
Dtsch Med Wochenschr 127:2280-4. 2002
Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutterStefan H Hohnloser
Department of Cardiology, Division of Electrophysiology, J W Goethe University, Frankfurt, Germany
J Am Coll Cardiol 44:99-104. 2004..The goal of the present study was to assess the efficacy and safety of intravenous tedisamil, a new antiarrhythmic compound, for conversion of recent-onset atrial fibrillation (AF) or atrial flutter (AFL) to normal sinus rhythm (NSR)...
Combined antiplatelet therapy in atrial fibrillation: review of the literature and future avenuesStefan H Hohnloser
Department of Medicine, J W Goethe University Hospital, Frankfurt, Germany
J Cardiovasc Electrophysiol 14:S60-3. 2003..The ACTIVE program began patient enrollment in spring 2003...
T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markersS H Hohnloser
Department of Cardiology, J W Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 9:1258-68. 1998....
Risk factor assessment: defining populations and individuals at riskStefan H Hohnloser
Department of Medicine, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
Cardiol Clin 26:355-66, v-vi. 2008....
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational studyStefan H Hohnloser
Department of Medicine, J W Goethe University, Frankfurt, Germany
J Am Coll Cardiol 41:2220-4. 2003....
Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic eraS H Hohnloser
Department of Medicine, J W Goethe University, Frankfurt, Germany
J Am Coll Cardiol 33:1895-902. 1999..The purpose of this study was to determine the prevalence, characteristics and the predictive value of nonsustained ventricular tachycardia (VT) for subsequent death and arrhythmic events after acute myocardial infarction (AMI)...
The defibrillator in acute myocardial infarction trial (DINAMIT): study protocolS H Hohnloser
Department of Medicine, Division of Cardiology, J W Goethe University, Frankfurt, Germany
Am Heart J 140:735-9. 2000..CONCLUSIONS: DINAMIT is the first prospective study to evaluate the benefit of ICD therapy for the primary prevention of sudden cardiac death in patients at high risk after acute myocardial infarction...
Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trialS H Hohnloser
JW Goethe University, Frankfurt, Germany
Lancet 356:1789-94. 2000..Restoration and maintenance of sinus rhythm is believed by many physicians to be superior to rate control only. However, there are no prospective data that compare both therapeutic strategies...
Benefit-risk assessment of current antiarrhythmic drug therapy of atrial fibrillationStefan H Hohnloser
Department of Cardiology, J W Goethe University, Frankfurt, Germany
Clin Cardiol 35:28-32. 2012..However, the drug was associated with increased mortality in patients with recently decompensated heart failure. Hence, antiarrhythmic drug therapy has to be evaluated in patients with AF on an individual patients basis...
Dronedarone in patients with congestive heart failure: insights from ATHENAStefan H Hohnloser
Division of Clinical Electrophysiology, Department of Cardiology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
Eur Heart J 31:1717-21. 2010..The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF...
Effect of dronedarone on cardiovascular events in atrial fibrillationStefan H Hohnloser
Department of Cardiology, J W Goethe University, Frankfurt, Germany
N Engl J Med 360:668-78. 2009..Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation...
Evidence regarding clinical use of microvolt T-wave alternansStefan H Hohnloser
Division of Cardiology, Department of Medicine, J W Goethe University, Frankfurt, Germany
Heart Rhythm 6:S36-44. 2009..In some recent studies involving primary prevention patients with prophylactically implanted cardioverter-defibrillators (ICDs), MTWA has not performed as well...
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W SubstudyStefan H Hohnloser
Department of Cardiology, Division of Electrophysiology, J W Goethe University, Frankfurt, Germany
J Am Coll Cardiol 50:2156-61. 2007..Our goal was to determine the risk of stroke or non-cerebral embolism associated with paroxysmal compared with sustained atrial fibrillation (AF)...
Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized studyT Klingenheben
Department of Medicine, Division of Cardiology, J.W. Goethe University, Frankfurt, Germany
J Am Coll Cardiol 38:2013-9. 2001..This applies particularly for beta-blocker therapy...
Septal Q waves in surface electrocardiographic lead V6 exclude minimal ventricular preexcitationF Bogun
Department of Internal Medicine, J W Goethe University, Frankfurt, Germany
Am J Cardiol 84:101-4, A9. 1999..The presence of a septal Q wave could be used to exclude minimal preexcitation with a high degree of reliability in both patients and controls before and after radiofrequency ablation...
Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable deviceC W Israel
Department of Medicine, J. W. Goethe University, Frankfurt, Germany
J Am Coll Cardiol 38:355-63. 2001..0001). CONCLUSIONS: The majority of patients with a history of AF show not only disorganized but also highly organized AT episodes, which can be successfully terminated by ATP...
Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapyC W Israel
Department of Medicine, J.W. Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 12:1121-8. 2001..Preventive pacing and atrial ATP algorithms represent two new functions that can be implemented safely into pacemaker systems for nonpharmacologic treatment of ATs in patients requiring pacemaker therapy...
Ablation of atypical atrial flutter guided by the use of concealed entrainment in patients without prior cardiac surgeryF Bogun
Division of Cardiology, JW Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 11:136-45. 2000..The purpose of this study was to assess prospectively the use of concealed entrainment (CE) in mapping of AF and to assess the clinical benefit of ablation of clinically relevant atypical AF...
Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testingM Zabel
Department of Medicine, Klinikum Benjamin Franklin, Free University of Berlin, Germany
J Am Coll Cardiol 36:1654-8. 2000..The study was done to determine whether variables of QT dispersion from the 12-lead electrocardiogram (ECG) are dependent on heart rate...
Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing functionC W Israel
J. W. Goethe University, Department of Medicine, Frankfurt, Germany
Pacing Clin Electrophysiol 24:183-90. 2001..Due to the VT/SVT discrimination algorithm, atrial sensing errors only led to misclassification in 4 % of all episodes, mainly due to atrial undersensing. No VT underdetection due to atrial oversensing occurred...
The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardiasDietmar Bansch
Department of Cardiology, St Georg Hospital, Hamburg, Germany
Circulation 110:1022-9. 2004..We hypothesized that patients with slow VTs (<200 bpm) may benefit from a long TDI and a dual-chamber detection algorithm compared with a conventionally programmed single-chamber ICD...
T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantationS H Hohnloser
Johann Wolfgang Goethe University, Frankfurt, Germany
Lancet 362:125-6. 2003..6% among the remaining patients. Testing of T-wave alternans seems to identify patients who are at low risk of ventricular tachyarrhythmic event and who may not benefit from defibrillator therapy...
Risk of development of delayed atrioventricular block after slow pathway modification in patients with atrioventricular nodal reentrant tachycardia and a pre-existing prolonged PR intervalY G Li
Department of Internal Medicine, Divison of Cardiology, J. W. Goethe University, Frankfurt, Germany
Eur Heart J 22:89-95. 2001..However, there is a significant risk of development of delayed atrioventricular block, particularly when the procedure results in total elimination of the slow pathway...
Clinical value of T-wave alternans assessmentThomas Klingenheben
Department of Medicine, Division of Cardiology/Clinical Electrophysiology, J. W. Goethe University, Frankfurt a. M, Germany
Card Electrophysiol Rev 6:323-8. 2002..e., pharmacological stimulation) in an attempt to reduce the proportion of incomplete tests in patients with insufficient increase in heart rate during exercise testing...
Bedside risk stratification after acute myocardial infarction: prospective evaluation of the use of heart rate and left ventricular functionOliver Mauss
Department of Cardiology, Division of Clinical Electrophysiology, J.W. Goethe University, D-60596 Frankfurt a. main, Germany
J Electrocardiol 38:106-12. 2005..2, P = .02), and HR assessed from the standard 12-lead ECG ( chi2 7.1, P = .008) as independent risk parameters. CONCLUSIONS: Bedside risk stratification of survivors of AMI is feasible using simple parameters such as age, LVEF, and HR...
Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation periodGabor Z Duray
Division of Cardiology, Section Clinical Electrophysiology, Department of Medicine, JW Goethe University, Frankfurt 60590, Germany
Europace 11:1462-8. 2009..Evaluation of cause-specific mortality in a large cohort of unselected implantable cardioverter defibrillator (ICD) recipients...
Mechanism of ventricular tachycardia termination by pacing at left ventricular sites in patients with coronary artery diseaseFrank Bogun
J W Goethe University, Division of Cardiology, Frankfurt, Germany
J Interv Card Electrophysiol 6:35-41. 2002..The purpose of this study was to compare the mechanisms by which pacing terminates VT at left ventricular (LV) sites with and without concealed entrainment (CE) in patients with prior myocardial infarction...
Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillatorsG C Grönefeld
Department of Medicine, J W Goethe University, Frankfurt am Main, Germany
Pacing Clin Electrophysiol 24:1519-24. 2001..Only in patients with documented efficacy of morphology discrimination should this feature be subsequently activated...
Torsade de pointes tachycardia as a rare manifestation of acute enteroviral myocarditisC Badorff
Division of Cardiology, Department of Internal Medicine IV, University of Frankfurt, Theodor Stern Kai 7, 60590 Frankfurt Main, Germany
Heart 86:489-90. 2001..This case shows that torsade de pointes may occur as a rare manifestation of viral myocarditis. Serial serological tests and endomyocardial biopsies may be helpful in establishing a diagnosis in such patients...
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidenceJoachim R Ehrlich
Division of Clinical Electrophysiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
Eur Heart J 27:512-8. 2006..This exciting field of investigation may lead to significant improvements in therapeutic options for AF patients...
Analysis during sinus rhythm of critical sites in reentry circuits of postinfarction ventricular tachycardiaFrank Bogun
Division of Cardiology, JW Goethe University, Frankfurt, Germany
J Interv Card Electrophysiol 7:95-103. 2002....
Acute severe cardiac decompensation during cardiac resynchronization therapy: what is the cause?Carsten W Israel
J W Goethe University, Department of Cardiology, Division of Electrophysiology, Frankfurt, Germany
Pacing Clin Electrophysiol 29:632-6. 2006
Suppression of atrial tachyarrhythmias by pacingCarsten W Israel
Department of Medicine, J.W. Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 13:S31-9. 2002..However, their clinical efficacy and optimal patient selection remain to be evaluated in prospective, well-designed clinical trials...
Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndromeFlorian T Wegener
Division of Cardiology, Section of Clinical Electrophysiology, J.W. Goethe-University, Theodor-Stern-Kai 7, D 60590 Frankfurt, Germany
Europace 10:112-3. 2008
Electrocardiographic hallmark of arrhythmogenic right ventricular cardiomyopathySergio Richter
J. W. Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 17:563-4. 2006
Novel anti-arrhythmic drugs for atrial fibrillation managementJoachim R Ehrlich
Division of Cardiology, Section of Electrophysiology, J W Goethe University, Frankfurt, Germany
Curr Vasc Pharmacol 5:185-95. 2007..This article summarizes relevant aspects of the cellular electrophysiology of AF and reviews the actions of pharmacological agents presently available or in development as novel anti-arrhythmic therapy...
Robotically enhanced placement of left ventricular epicardial electrodes during implantation of a biventricular implantable cardioverter defibrillator systemPeter Kleine
Department of Thoracic and Cardiovascular Surgery, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
Pacing Clin Electrophysiol 25:989-91. 2002..This report demonstrates the feasibility of totally endoscopic direct placement of an epicardial stimulation lead on the left ventricle using the daVinci surgical system...
External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy applicationJohannes C Manegold
Division of Cardiology, Department of Medicine, J W Goethe University Hospital, Theodor Stern Kai 7, Frankfurt, Germany
Eur Heart J 28:1731-8. 2007..This prospective study evaluated the safety and efficacy of ECV comparing mono- to biphasic shock waveforms in patients with implanted rhythm devices...
Reversible exercise-induced advanced atrioventricular block due to cardiac sarcoidosisLothar Rossig
Department of Internal Medicine, JW Goethe University, Frankfurt, Germany
Heart Rhythm 4:116. 2007
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implicationsJoern Schmitt
Section of Electrophysiology, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
Eur Heart J 30:1038-45. 2009..These observations emphasize the need for prospective studies evaluating optimal therapeutic approaches for patients with AMI complicated by AF...
ICD therapy in coronary artery disease. A reappraisal in 2005Gerian Grönefeld
Division of Cardiology, Department of Medicine, J W Goethe University, Frankfurt Main, Germany
Herz 30:82-6. 2005..There is convincing evidence that ICD benefit in coronary patients accrues after a considerable time having elapsed from the most recent infarct, presumably at least 6 months or perhaps longer...
Properties of a time-dependent potassium current in pig atrium: evidence for a role of kv1.5 in repolarizationJoachim R Ehrlich
Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
J Pharmacol Exp Ther 319:898-906. 2006..5 expression, and shows a pharmacological profile typical of K(v)1.5-dependent currents...
Towards a consensus in rate versus rhythm control for management of atrial fibrillation: insights from the PIAF trialGerian Grönefeld
Department of Medicine, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
Card Electrophysiol Rev 7:113-7. 2003..This review summarizes the rationale and results of PIAF in an attempt to update and discuss the clinical relevance of these findings in the light of the other studies and with regard to individual treatment options...
Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231Joachim R Ehrlich
Division of Cardiology, J W Goethe Universitat, Frankfurt, Germany
J Cardiovasc Pharmacol 51:380-7. 2008..Atrial-selective drug therapy represents a novel therapeutic approach for atrial fibrillation management. The aim of the present study was to investigate the mechanism of hKv1.5 channel inhibition by the atrial-selective compound AVE1231...
Electrophysiologic refinement of risk stratification: can we achieve the goal?Carsten W Israel
Department of Medicine, Division of Cardiology, J W Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 15:177-8. 2004
Biventricular pacing does not affect microvolt T-wave alternans in heart failure patientsJoachim R Ehrlich
Division of Clinical Electrophysiology, J W Goethe University, Frankfurt, Germany
Heart Rhythm 5:348-52. 2008..Accordingly, it is unknown whether biventricular (BiV) pacing might influence MTWA test results...
Atrial-selective approaches for the treatment of atrial fibrillationJoachim R Ehrlich
Division of Cardiology, Section of Electrophysiology, J W Goethe University, Frankfurt, Germany
J Am Coll Cardiol 51:787-92. 2008..It also mentions favorable interventions on the milieu in terms of conventional (such as antifibrotic effects of angiotensin-system antagonism) and innovative gene-therapy approaches that might add to future AF therapeutic options...
What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death?G Gronefeld
Department of Medicine, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
Cardiovasc Res 50:232-41. 2001..One future research avenue concerns the more detailed analysis of changes in cardiac autonomic tone preceding the occurrence of sustained ventricular tachyarrhythmias which can be assessed from the electrogram storage of the ICD...
Milestones in the management of atrial fibrillationJoachim R Ehrlich
Division of Cardiology, Section of Electrophysiology, Goethe University, Frankfurt, Germany
Heart Rhythm 6:S62-7. 2009..In summary, the development of novel treatment strategies for AF is highly dynamic and productive. Years to come will likely witness significant changes in perspective and prognosis of affected patients...
Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: results from a prospective randomized trialCarsten W Israel
Department of Medicine, Division of Cardiology, J.W. Goethe-University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
J Cardiovasc Electrophysiol 14:954-9. 2003..CONCLUSION: Automatic overdrive pacing after AT termination did not prevent IRAT, mainly due to insufficient overdrive suppression even at 120 beats/min and the delay between AT termination and PMOP intervention...
Pacing to prevent atrial fibrillationCarsten W Israel
Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany
J Cardiovasc Electrophysiol 14:S20-6. 2003..CONCLUSION: Pacing seems to be able to suppress ATs in a minority of patients; however, prospective identification of responders to different pacing modalities does not appear to be feasible at the present time...
Dronedarone: an emerging agent with rhythm- and rate-controlling effectsFlorian T Wegener
Division of Electrophysiology, Department of Cardiology, J. W. Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 17:S17-20. 2006....
Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated cardiomyopathyThomas Klingenheben
Division of Clinical Electrophysiology, Department of Cardiology, JW Goethe University, Frankfurt, Germany
J Electrocardiol 41:306-11. 2008..Noninvasive arrhythmia risk stratification in patients with nonischemic dilated cardiomyopathy (DCM) using autonomic markers have yielded disappointing results. Heart rate turbulence is a new method to assess cardiac autonomic function...
Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rateGabor Z Duray
Section Clinical Electrophysiology, Division of Cardiology, Department of Medicine, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt a M, Germany
Europace 10:48-52. 2008..It is less clear whether this includes patients with pre-existing right ventricular pacemaker/defibrillator systems, particularly with respect to implantation success and clinical benefit...
Usefulness of atrial pacing for prevention and termination of atrial tachyarrhythmias in a patient with persistent atrial fibrillationCarsten W Israel
J. W. Goethe University Hospital, Department of Medicine, Frankfurt, Germany
Pacing Clin Electrophysiol 25:1527-9. 2002..Thus, selected patients with persistent AF may benefit from preventive atrial pacing since the tachyarrhythmia can organize intermittently to a degree sufficient for pace termination...
Bundle branch reentrant tachycardia in patients with apparent normal His-Purkinje conduction: the role of functional conduction impairmentYi-Gang Li
Department of Internal Medicine, Division of Cardiology, J.W. Goethe-University, Frankfurt, Germany
J Cardiovasc Electrophysiol 13:1233-9. 2002..CONCLUSION: A prolonged HV interval during SR is not a prerequisite for BBRT. Functional His-Purkinje system abnormalities appear to be the electrophysiologic substrate for this specific type of BBRT...
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): rationale, design and specific aimsGerian Grönefeld
Department of Medicine, Division of Cardiology, J W Goethe University, Frankfurt, Germany
Card Electrophysiol Rev 7:447-51. 2003..This paper summarizes the rationale, design and specific contributions of the Defibrillator in Myocardial infarction trial (DINAMIT) in comparison to other relevant studies on primary prevention of sudden cardiac death...
Beta-blocker therapy in atrial fibrillationGerian C Gronefeld
University Hospital Frankfurt, Frankfurt, Germany
Pacing Clin Electrophysiol 26:1607-12. 2003..The article summarizes available clinical studies and reviews some experimental data examining the treatment effects of antiadrenergic therapy in AF...
Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized studyGerian C Gronefeld
Department of Medicine, Division of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
Eur Heart J 24:1430-6. 2003..This prospective study evaluated QoL in patients with symptomatic persistent AF randomized to therapy aiming at rate versus rhythm control...
Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failureThomas Klingenheben
Division of Clinical Electrophysiology, Department of Cardiology, J.W. Goethe University, D-60590 Frankfurt, Germany
J Cardiovasc Electrophysiol 16:620-4. 2005..CONCLUSION: Patients with nonischemic cardiomyopathy and patients with tachyarrhythmic complications have more extensive MTWA possibly reflecting more extensive myocardial damage and a higher arrhythmia propensity...
Usefulness of risk stratification for future cardiac events in infarct survivors with severely depressed versus near-normal left ventricular function: results from a prospective long-term follow-up studyThomas Klingenheben
Department of Medicine, Division of Clinical Electrophysiology, J.W. Goethe University Hospital, Frankfurt, Germany
Ann Noninvasive Electrocardiol 8:68-74. 2003..Accordingly, cost effectiveness of risk stratification and subsequent preventive therapy may be improved by restricting risk stratification to patients with impaired LV function...
Immediate reinitiation of atrial tachyarrhythmias after spontaneous restoration of sinus rhythm in patients with an implanted monitoring deviceCarsten W Israel
J. W. Goethe University, Division of Cardiology, Frankfurt, Germany
Pacing Clin Electrophysiol 26:1317-25. 2003..In conclusion, IRAT is frequent after spontaneous restoration of SR. Changes of atrial electrophysiological properties promoting IRAT may already develop during AT of short duration...
How to analyze T-wave alternansSergio Richter
Department of Cardiology, Division of Clinical Electrophysiology, J.W. Goethe University, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany
Heart Rhythm 2:1268-71. 2005
Recent primary prevention implantable cardioverter defibrillator trialsGabor Duray
Department of Medicine, J. W. Goethe University, Frankfurt am Main, Germany
Curr Opin Cardiol 21:15-9. 2006..SUMMARY: Taken together, these trials allow an evidence-based approach to primary prevention of sudden cardiac death in patients with both ischemic and non-ischemic cardiomyopathy...
Severe intracranial bleeding mimicking acute inferior myocardial infarction with right ventricular involvementF Jung
Division of Cardiology, Department of Medicine, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
Cardiology 95:48-50. 2001..A rapid diagnostic evaluation has to be initiated to rule out a myocardial infarction and to diagnose intracranial hemorrhage before the use of thrombolytic or anticoagulant therapy...
Tachycardia after pacemaker implantation in a patient with complete atrioventricular blockGabor Z Duray
Division of Clinical Electrophysiology, Department of Cardiology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
Europace 9:900-3. 2007..Dual-chamber devices therefore have to be programmed accordingly, activating dedicated reactions after ventricular premature beats and automatic ELT detection and termination algorithms...
Thromboembolic risk of patients referred for radiofrequency catheter ablation of typical atrial flutter without prior appropriate anticoagulation therapyGerian C Gronefeld
J W Goethe University, Frankfurt, Germany
Pacing Clin Electrophysiol 26:323-7. 2003..Radiofrequency catheter ablation of isthmus dependent atrial flutter is considered the therapy of choice. There is, however, controversy with regard to the thrombogenicity of atrial flutter in comparison with atrial fibrillation...
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient careCarsten W Israel
J. W. Goethe University Hospital, Department of Medicine, Division of Cardiology, Frankfurt, Germany
J Am Coll Cardiol 43:47-52. 2004..Of particular note, AF relapses >48 h remained totally asymptomatic in a significant proportion of patients. Freedom from AF for > or =3 months did not preclude subsequent long-lasting AF recurrence...
Assessment of microvolt T-wave alternans in high-risk patients with the congenital long-QT syndromeJörn Schmitt
Division of Cardiology, Section of Electrophysiology, J W Goethe University, Frankfurt, Germany
Ann Noninvasive Electrocardiol 14:340-5. 2009..The role of MTWA testing in patients with LQTS has not been established. Objective: To determine the diagnostic value of MTWA testing in high-risk patients with LQTS...
"Twiddler syndrome" in a subpectorally implanted cardioverter defibrillatorGerian Grönefeld
Department of Medicine, J W Goethe University, Frankfurt Main, Germany
J Cardiovasc Electrophysiol 13:94. 2002
Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillationGabor Z Duray
J W Goethe University, Frankfurt, Germany
Curr Opin Cardiol 25:53-8. 2010..To describe the electrophysiological profile and the clinical portfolio of dronedarone, a new multichannel-blocking antiarrhythmic drug developed for the treatment of atrial fibrillation...
Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillatorStefan H Hohnloser
J.W. Goethe University, Department of Medicine, Division of Cardiology, Frankfurt, Germany
Circulation 107:941-6. 2003
[Pathophysiologic relevance and prognostic value of QT dispersion.]M Zabel
Abt Kardiologie und Nephrologie, Medizinische Klinik IV, Theodor Stern Kai 7, 60590, Frankfurt
Herzschrittmacherther Elektrophysiol 8:223-30. 1997..In other populations, such as postinfarction patients, patients with congestive heart failure or patients with ventricular tachycardia or ventricular fibrillation, determination of QT dispersion is probably not of clinical value...
Catheter ablation of frequently recurring ventricular fibrillation in a patient after aortic valve repairYi-Gang Li
Department of Medicine, Division of Cardiology, J.W. Goethe-University, Frankfurt, Germany
J Cardiovasc Electrophysiol 15:90-3. 2004..VPB originating from the Purkinje system may be one possibility for VF initiation in patients with structural heart disease. Eliminating these sources of VPBs by catheter ablation can prevent recurrent VF in such patients...
Coronary sinus side branches for cardiac resynchronization therapy: prospective evaluation of availability, implant success, and procedural determinantsGabor Z Duray
Department of Medicine, Division of Cardiology, Section Clinical Electrophysiology, J W Goethe University, Frankfurt, Germany
J Cardiovasc Electrophysiol 19:489-94. 2008..There are only sparse data concerning individual coronary side branch (CS-SB) anatomy with respect to LV lead implantation for cardiac resynchronization therapy (CRT)...
Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devicesGabor Z Duray
Division of Cardiology, Section Clinical Electrophysiology, Department of Medicine, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt Main, Germany
Europace 11:297-302. 2009..The incidence of hardware-related complications in single (SC)-, dual (DC)-, and triple (BiV)-chamber devices requiring surgical revision has not been investigated systematically...
Interpretation and classification of microvolt T wave alternans testsDaniel M Bloomfield
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
J Cardiovasc Electrophysiol 13:502-12. 2002..As this technology becomes more widely available, physicians will be called upon to interpret microvolt TWA tracings. This review seeks to establish uniform standards for the clinical interpretation of microvolt TWA tracings...
Dronedarone for prevention of atrial fibrillation: a dose-ranging studyPaul Touboul
Division of Cardiology, Hopital Cardiologique, Lyon, France
Eur Heart J 24:1481-7. 2003..This study was designed to determine the most appropriate dose of dronedarone for prevention of atrial fibrillation (AF) after cardioversion...
Rhythm or rate control in atrial fibrillation: insights from the randomized controlled trialsGerian Grönefeld
J Cardiovasc Pharmacol Ther 8:S39-44. 2003..The four randomized trials clearly demonstrate that continuous anticoagulation is mandatory in all patients with atrial fibrillation and risk factors for stroke, irrespective of the initial therapeutic approach of rhythm or rate control...
Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trialPaul Dorian
Division of Cardiology, St Michael s Hospital University of Toronto, Toronto, Ontario, Canada
J Am Coll Cardiol 52:1076-83. 2008....
Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?Antonis A Armoundas
Massachusetts General Hospital, USA
Nat Clin Pract Cardiovasc Med 2:522-8. 2005..In response, patients with a low ejection fraction who are being considered for implantable cardioverter-defibrillator therapy should undergo MTWA testing as part of their evaluation...
Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillatorsT Jared Bunch
Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Circulation 115:2451-7. 2007
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policyGillian D Sanders
Duke Clinical Research Institute, Duke Medical Center, Durham, NC 27715, USA
Am Heart J 153:951-9. 2007....
Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, LouisianaDwight W Reynolds
Cardiovascular Section, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190, USA
Heart Rhythm 2:1025-33. 2005
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterBramah N Singh
Cardiology Division, Veterans Affairs Greater Los Angeles Healthcare System and the David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA
N Engl J Med 357:987-99. 2007..Dronedarone is a new antiarrhythmic agent pharmacologically related to amiodarone but developed to reduce the risk of side effects...
[Pharmacological therapy of atrial fibrillation and atrial flutter]Gerian C Gronefeld
Abteilung Kardiologie, Medizinische Klinik IV, Johann Wolfgang Goethe Universität Frankfurt am Main
Herz 27:329-44. 2002....
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillatorCraig M Pratt
The Methodist DeBakey Heart Center and the Section of Cardiology, Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
Am J Cardiol 95:274-6. 2005..The primary efficacy end points are time to all-cause shocks and time to all-cause shocks plus symptomatic ventricular arrhythmic events triggering antitachycardia pacing measured from randomization...
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillatorPaul Dorian
Division of Cardiology, St Michael s Hospital, 30 Bond St, Toronto, Ontario M5B 1W8, Canada
Circulation 110:3646-54. 2004....
Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, CaliforniaAnne B Curtis
Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610, USA
J Am Coll Cardiol 44:1550-6. 2004....
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)Jeff S Healey
Population Health Research Institute, McMaster University, 237 Barton St E, Hamilton, Ontario, Canada
Stroke 39:1482-6. 2008..However, because OAC carries important bleeding complications, risk stratification schemes have been devised to identify patients for whom the absolute benefits of OAC exceed its risks...
